ES2258298T3 - Proceso para la preparacion de ampicilina. - Google Patents
Proceso para la preparacion de ampicilina.Info
- Publication number
- ES2258298T3 ES2258298T3 ES98924672T ES98924672T ES2258298T3 ES 2258298 T3 ES2258298 T3 ES 2258298T3 ES 98924672 T ES98924672 T ES 98924672T ES 98924672 T ES98924672 T ES 98924672T ES 2258298 T3 ES2258298 T3 ES 2258298T3
- Authority
- ES
- Spain
- Prior art keywords
- apa
- concentration
- process according
- ampicillin
- phenylglycine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 title claims abstract description 32
- 229960000723 ampicillin Drugs 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims description 21
- 238000002360 preparation method Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 30
- 238000005917 acylation reaction Methods 0.000 claims abstract description 22
- KIYRSYYOVDHSPG-SSDOTTSWSA-N (2r)-2-amino-2-phenylacetamide Chemical compound NC(=O)[C@H](N)C1=CC=CC=C1 KIYRSYYOVDHSPG-SSDOTTSWSA-N 0.000 claims abstract description 21
- 239000011541 reaction mixture Substances 0.000 claims abstract description 16
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 13
- 150000005331 phenylglycines Chemical class 0.000 claims abstract description 13
- 230000010933 acylation Effects 0.000 claims abstract description 12
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims abstract 15
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims abstract 15
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims 2
- 238000001139 pH measurement Methods 0.000 claims 1
- 238000010923 batch production Methods 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 23
- 150000003952 β-lactams Chemical class 0.000 description 10
- 108010073038 Penicillin Amidase Proteins 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 5
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 241000589220 Acetobacter Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PYHRZPFZZDCOPH-QXGOIDDHSA-N (S)-amphetamine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C[C@H](N)CC1=CC=CC=C1.C[C@H](N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-QXGOIDDHSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 241000726092 Aphanocladium Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000588752 Kluyvera Species 0.000 description 1
- 241000721603 Mycoplana Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 241000586779 Protaminobacter Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960003311 ampicillin trihydrate Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
- C12P37/04—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin by acylation of the substituent in the 6 position
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1006266A NL1006266C2 (nl) | 1997-06-10 | 1997-06-10 | Werkwijze voor de bereiding van ampicilline. |
| NL1006266 | 1997-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2258298T3 true ES2258298T3 (es) | 2006-08-16 |
Family
ID=19765126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98924672T Expired - Lifetime ES2258298T3 (es) | 1997-06-10 | 1998-05-25 | Proceso para la preparacion de ampicilina. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7029885B2 (OSRAM) |
| EP (1) | EP0988393B1 (OSRAM) |
| KR (1) | KR100508290B1 (OSRAM) |
| CN (1) | CN1115417C (OSRAM) |
| AT (1) | ATE319849T1 (OSRAM) |
| AU (1) | AU7677798A (OSRAM) |
| BR (1) | BR9810020A (OSRAM) |
| ES (1) | ES2258298T3 (OSRAM) |
| IN (1) | IN186863B (OSRAM) |
| NL (1) | NL1006266C2 (OSRAM) |
| TR (1) | TR200000201T2 (OSRAM) |
| WO (1) | WO1998056946A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6538045B1 (en) * | 1999-12-23 | 2003-03-25 | Dsm N.V. | Optical fiber coating compositions containing secondary or tertiary amino silicone-containing additive |
| EP2723882B1 (en) | 2011-06-23 | 2019-05-01 | Centrient Pharmaceuticals Netherlands B.V. | Process for preparing 3'-thiosubstituted cephalosporins employing a penicillin g acylase |
| EP2723881A2 (en) | 2011-06-23 | 2014-04-30 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Novel crystalline cefoperazone intermediate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2188608A5 (en) * | 1972-06-14 | 1974-01-18 | Aries Robert | Penicillins prepn by acylating 6-apa - in presence of catalytic enzymes using free acids |
| EP0537255B1 (en) * | 1990-07-04 | 2006-02-15 | DSM IP Assets B.V. | Process for preparation of beta-lactams |
| IT1243800B (it) * | 1990-08-28 | 1994-06-28 | Sclavo Spa | Procedimento migliorato per la preparazione di cefalosporine |
| BE1007296A3 (nl) * | 1993-07-19 | 1995-05-09 | Dsm Nv | Werkwijze voor de bereiding van een beta-lactamderivaat. |
| US6048708A (en) * | 1994-07-18 | 2000-04-11 | Gist-Brocades B.V. | Process for preparation of β-lactams at constantly high concentration of reactants |
| BE1009264A3 (nl) * | 1995-03-31 | 1997-01-07 | Dsm Nv | Werkwijze voor de winning van ampicilline. |
| NL1007077C2 (nl) | 1997-09-19 | 1999-03-22 | Dsm Nv | Werkwijze voor de winning van een ß-lactam antibioticum. |
| NL1007076C2 (nl) | 1997-09-19 | 1999-03-22 | Dsm Nv | Werkwijze voor de winning van een ß-lactam antibioticum. |
| NL1007302C2 (nl) | 1997-10-17 | 1999-04-20 | Dsm Nv | Werkwijze voor de bereiding van een ß-lactam antibioticum. |
-
1997
- 1997-06-10 NL NL1006266A patent/NL1006266C2/nl not_active IP Right Cessation
-
1998
- 1998-05-25 AU AU76777/98A patent/AU7677798A/en not_active Abandoned
- 1998-05-25 WO PCT/NL1998/000295 patent/WO1998056946A1/en not_active Ceased
- 1998-05-25 CN CN98807876A patent/CN1115417C/zh not_active Expired - Lifetime
- 1998-05-25 EP EP98924672A patent/EP0988393B1/en not_active Expired - Lifetime
- 1998-05-25 ES ES98924672T patent/ES2258298T3/es not_active Expired - Lifetime
- 1998-05-25 KR KR10-1999-7011645A patent/KR100508290B1/ko not_active Expired - Fee Related
- 1998-05-25 AT AT98924672T patent/ATE319849T1/de active
- 1998-05-25 TR TR2000/00201T patent/TR200000201T2/xx unknown
- 1998-05-25 BR BR9810020-3A patent/BR9810020A/pt not_active Application Discontinuation
- 1998-06-05 IN IN1224MA1998 patent/IN186863B/en unknown
-
1999
- 1999-12-10 US US09/457,765 patent/US7029885B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE319849T1 (de) | 2006-03-15 |
| BR9810020A (pt) | 2000-09-19 |
| CN1265706A (zh) | 2000-09-06 |
| KR100508290B1 (ko) | 2005-08-17 |
| EP0988393B1 (en) | 2006-03-08 |
| KR20010013635A (ko) | 2001-02-26 |
| IN186863B (OSRAM) | 2001-11-24 |
| WO1998056946A1 (en) | 1998-12-17 |
| EP0988393A1 (en) | 2000-03-29 |
| US7029885B2 (en) | 2006-04-18 |
| NL1006266C2 (nl) | 1998-12-14 |
| US20020009769A1 (en) | 2002-01-24 |
| TR200000201T2 (tr) | 2000-06-21 |
| AU7677798A (en) | 1998-12-30 |
| CN1115417C (zh) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2086250C (en) | Process for preparation of beta-lactams | |
| US6048708A (en) | Process for preparation of β-lactams at constantly high concentration of reactants | |
| EP0839192A1 (en) | An improved immobilized penicillin g acylase | |
| US20100190206A1 (en) | Process for the preparation of immobilized recombinant penicillin acylase catalyst from achromobacter sp. ccm 4824 expressed in e. coli bl 21 ccm 7394 and its use for the synthesis of beta-lactam antibiotics | |
| US6287799B1 (en) | Process for the preparation of aβ-lactam antibiotic | |
| US7029885B2 (en) | Process for the preparation of ampicillin | |
| CN101090978A (zh) | 合成头孢克洛的方法 | |
| US6060268A (en) | Penicillin G acylase immobilized with a crosslinked mixture of gelled gelatin and amino polymer | |
| EP1017698A1 (en) | PROCESS FOR RECOVERY OF A (beta)-LACTAM ANTIBIOTIC | |
| EP1416054B1 (en) | Simple enzymatic process for preparing cefazolin | |
| EP0473008A2 (en) | Improved process for preparing penicillins and cephalosporins | |
| WO1999015532A1 (en) | PROCESS FOR RECOVERY OF A β-LACTAM ANTIBIOTIC | |
| US5753458A (en) | Acylation method for penicillins and cephalosporins | |
| MXPA00003769A (en) | PROCESS FOR THE PREPARATION OF A&bgr;-LACTAM ANTIBIOTIC | |
| WO1999031109A1 (en) | COMPLEXES OF ss-LACTAM ANTIBIOTICS AND 1-NAPHTHOL | |
| CA2167118A1 (en) | Enzymatic process for producing penicillins and cephalosporins | |
| ES2359600T3 (es) | Proceso para sililar beta-lactamas. | |
| WO2001030783A1 (en) | PROCESS FOR THE PREPARATION OF A β-LACTAM ANTIBIOTIC | |
| MXPA00010537A (en) | A METHOD FOR CRYSTALLIZING A&bgr;-LACTAM ANTIBIOTIC |